We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$12.7M
Cap. Flow
-$12.5M
Cap. Flow %
-7.34%
Top 10 Hldgs %
60.5%
Holding
104
New
11
Increased
13
Reduced
10
Closed
4
Avg Time Held
3 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$1.77M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$1.29M
3
TGTX icon
TG Therapeutics
TGTX
+$892K
4
KYNB icon
Kyntra Bio
KYNB
+$849K
5
GILD icon
Gilead Sciences
GILD
+$763K

Top Sells

Rank Stock Value
1
SRCL icon
Stericycle Inc
SRCL
+$6.7M
2
CCXI icon
ChemoCentryx, Inc.
CCXI
+$3.69M
3
KKR icon
KKR & Co
KKR
+$2.8M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$2.73M
5
BLU
BELLUS Health Inc.
BLU
+$2.47M

Sector Composition

Rank Sector Weight
1 Healthcare 41.75%
2 Financials 15.96%
3 Industrials 12.97%
4 Technology 9.76%
5 Communication Services 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.89B
$23.6M 13.87%
397,610
-40,075
-9% -$2.73M
2013 Q2
29 quarters
UPLD icon
2
Upland Software
UPLD
$9.97M
$15.3M 8.99%
40,650
– –
2017 Q4
11 quarters
APO icon
3
Apollo Global Management
APO
$65.4B
$13.4M 7.88%
300,000
– –
2017 Q2
13 quarters
FTAI icon
4
FTAI Aviation
FTAI
$16.9B
$12M 7.04%
819,700
– –
2020 Q2
1 quarter
SRCL icon
5
DELISTED
Stericycle Inc
SRCL
$10.1M 5.92%
160,000
-109,083
-41% -$6.7M
2019 Q1
6 quarters
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.12T
$8.23M 4.83%
112,000
– –
2019 Q1
6 quarters
FSK icon
7
FS KKR Capital
FSK
$2.85B
$6.27M 3.68%
395,175
– –
2019 Q3
4 quarters
CLMT icon
8
Calumet Specialty Products
CLMT
$5.08B
$5.15M 3.02%
2,020,000
– –
2018 Q1
10 quarters
PFE icon
9
Pfizer
PFE
$169B
$4.84M 2.84%
139,023
– –
2013 Q2
29 quarters
LKQ icon
10
LKQ Corp
LKQ
$5.62B
$4.16M 2.44%
150,000
– –
2018 Q2
9 quarters
KKR icon
11
KKR & Co
KKR
$77.4B
$3.43M 2.01%
100,000
-80,000
-44% -$2.8M
2020 Q1
2 quarters
ABBV icon
12
AbbVie
ABBV
$504B
$3.31M 1.94%
37,769
– –
2015 Q2
21 quarters
KW icon
13
DELISTED
Kennedy-Wilson Holdings
KW
$3.05M 1.79%
210,000
– –
2020 Q2
1 quarter
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.92M 1.71%
37,531
+1,000
+3% +$68.8K
2018 Q2
9 quarters
BMY icon
15
Bristol-Myers Squibb
BMY
$122B
$2.8M 1.64%
46,409
– –
2017 Q1
14 quarters
TRIL
16
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.5M 1.47%
176,215
-88,010
-33% -$877K
2020 Q1
2 quarters
KDMN
17
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.4M 1.41%
612,000
+174,400
+40% +$733K
2019 Q3
4 quarters
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.24M 1.31%
9,178
+386
+4% +$120K
2017 Q3
12 quarters
JPM icon
19
JPMorgan Chase
JPM
$902B
$2.22M 1.3%
23,050
– –
2013 Q2
29 quarters
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
$2.02M 1.19%
112,707
+7,100
+7% +$174K
2020 Q1
2 quarters
AUPH icon
21
Aurinia Pharmaceuticals
AUPH
$2.2B
$1.98M 1.16%
134,600
+19,790
+17% +$287K
2020 Q1
2 quarters
XENE icon
22
Xenon Pharmaceuticals
XENE
$3.24B
$1.96M 1.15%
177,000
+8,000
+5% +$94.1K
2017 Q3
12 quarters
CHRS icon
23
Coherus Oncology
CHRS
$153M
$1.82M 1.07%
99,493
-5,073
-5% -$94.4K
2017 Q2
13 quarters
BDSI
24
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.8M 1.05%
481,930
-23,600
-5% -$100K
2018 Q1
10 quarters
MPLX icon
25
MPLX
MPLX
$59B
$1.57M 0.92%
100,000
– –
2018 Q1
10 quarters
1
2 3 4 5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q3 2020 Portfolio in Review

As of Q3 2020, David M. Knott held 104 positions worth $170M, down 7% from $183M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

David M. Knott withdrew a net $12.5M in Q3 2020, closing 4 positions and reducing 10 holdings. Its most notable exit was BELLUS Health Inc., an estimated $2.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 45% a quarter earlier, followed by Financials and Industrials.

Against the trend, David M. Knott opened a new position in Vapotherm, Inc. Common Stock worth $1.42M.

  • David M. Knott's largest Q3 2020 buy was Vapotherm, Inc. Common Stock: 6,125 shares worth $1.42M.
  • David M. Knott added most to TG Therapeutics in Q3 2020, an estimated $892K increase.
  • David M. Knott's biggest Q3 2020 reduction was Stericycle Inc, cutting an estimated $6.7M.
  • David M. Knott fully exited BELLUS Health Inc. in Q3 2020, selling an estimated $2.47M.
  • David M. Knott's ten largest holdings make up 61% of its $170M portfolio in Q3 2020.
  • David M. Knott opened 11 new positions and closed 4 in Q3 2020.
  • David M. Knott's portfolio value fell 7% quarter-over-quarter to $170M.

Based on David M. Knott's 13F filing for Q3 2020, filed 13 Nov 2020.